Effect of Rifampicin on the Pharmacokinetics of Apatinib
Clinical trial NCT02836821 · COMPLETED
Trial details
- NCT number
- NCT02836821
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-02-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.